Merck & Co. Expands Haematology Portfolio with US$6.7 B Acquisition of Terns Pharmaceuticals
By Nikita Negi
Pharma Deals Review: Vol 2026 Issue 3 (Table of Contents)
Published: 31 Mar-2026
DOI: 10.3833/pdr.v2026.i3.3005 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a strategic move to reinforce its oncology pipeline, Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS